Bispecific antibody Image: Tecvayli

Tecvayli, EMA approval, Multiple myeloma, Johnson & Johnson, Bispecific antibody

Janssen’s Bispecific Antibody Tecvayli Receives European Commission Approval for Reduced Dosing Frequency

Anika Sharma

The Janssen Pharmaceutical Companies of Johnson & Johnson have proudly unveiled a significant advancement in cancer treatment. The European Commission ...